Brought to you by 
Seegene raises $16.6mm in IPO on Korean exchange
Sep 2010
Executive Summary
Molecular diagnostics firm Seegene Inc. completed a $16.6mm initial public offering on Kosdaq (Korea Securities Dealers Automated Quotations). It sold 636.5k shares at $26.16. The company says it will also attempt an IPO on Nasdaq in three years.
Deal Industry
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Seegene raises $16.6mm in IPO on Korean exchange
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice